Back to search

Article

p53+/-Rb1-ASCL1low phenotype predicts better prognosis after surgical resection in large cell neuroendocrine carcinoma: a molecular characteristic and clinical-pathological investigation of lung neuroendocrine tumors

2020-11-13

Abstract excerpt

<h4>Background: </h4> Based on morphology, necrosis degree, and proliferation status, lung neuroendocrine tumors (NETs) are commonly divided into four subtypes: typical carcinoid (TC), atypical carcinoid (AC), large cell neuroendocrine carcinoma (LCNEC), and small cell lung carcinoma (SCLC). However, cases difficult to classify still exist in diagnosis. <h4>Methods: </h4> We immunohistochemically investigated the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee3f38ce-f554-589f-b77d-906bb2afe441
DOI
10.21203/rs.3.rs-107219/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
p53+/-Rb1-ASCL1low&nbsp;phenotype&nbsp;predicts better prognosis after surgical resection in large cell neuroendocrine carcinoma: a molecular characteristic and clinical-pathological investigation of lung neuroendocrine tumorsDOI 10.21203/rs.3.rs-107219/v1
P53 +/- Rb1 - ASCL1 low&nbsp;Phenotype&nbsp;Predicts Better Prognosis after Surgical Resection in Large Cell Neuroendocrine Carcinoma: A Molecular Characteristic and Clinical-Pathological Investigation of Lung Neuroendocrine TumorsSemantic proximity
p53+/-Rb1-ASCL1low&nbsp;Phenotype Predicts Better Prognosis After Surgical Resection in Large Cell Neuroendocrine Carcinoma: a Molecular Characteristic and Clinical-pathological Investigation of Lung Neuroendocrine TumorsSemantic proximity
The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the LungSemantic proximity
Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and TreatmentsSemantic proximity
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impactsSemantic proximity
Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined GroupsSemantic proximity
Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.Semantic proximity
Genomic Profiling and Clinicopathological Characteristics of Neuroendocrine Tumors of the Lung in East Asian Patients.Semantic proximity
Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and OncologistsSemantic proximity
Progression of low-grade neuroendocrine tumors (NET) to high-grade neuroendocrine neoplasms harboring the prototypical neuroendocrine carcinoma (NEC) co-alteration of RB1 and TP53.Semantic proximity
Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes.Semantic proximity
Large-cell Basaloid Adenocarcinoma of the Lung: A Clinicopathologic Study of 12 Cases of a Distinctive Form of Lung Cancer Often Mistaken for Large-cell Neuroendocrine Carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.